830047

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Sponsor, Contract Research Organization